US Biomax, Inc.
 

Tissue Array and Tissue Microarray from US Biomax

More than 2200 types of tissue array or tissue microarray to choose from.


Tissue Arrays (Microarrays)

Tissue array or tissue microarray from US Biomax includes normal, malignant or metastatic formats. Tissue arrays and Tissue microarrays can be used to validate clinical relevance of potential biological targets in the development of diagnostics, therapeutics and study new protein markers and genes. Tissue arrays (tissue microarrays or tissue-chips) contain protein, RNA, or DNA molecules, thus provides high throughput platforms for the rapid analysis of molecular markers associated with disease diagnosis, prognosis and therapeutics in patients. US Biomax also provides custom tissue array as well as services of immunohistochemistry (IHC) staining and In situ hybridization (ISH) on tissue array or tissue microarray.

Tissue arrays are listed by organ types on the left panel of this page.

Our customers come from a variety of places, including happy customers from NIH, big pharmaceuticals, such as Merck Co., Roche, GSK, Novartis, Genentech, Biogen IDC, etc, big vendors, such as Fisher Scientific and VWR and almost all major universities and research institutions in the United States, not mentioning our strong distribution channels all over the world. We dare to say that tissue arrays from US Biomax have the highest quality in the industry and maintain the most stringent standards on quality controls. US Biomax has been staying at the forefront to maintain the most varieties and quantities of tissue arrays.

Featured US Biomax tissue arrays:

Most viewed tissue microarrays (Hits):

BR1001, Breast cancer tissue array with matched carcinoma metastasis to lymph nodes, 50 cases/100 cores, replaced by BR1004
BR6161, High-density breast cancer tissue array, with stage, grade and normal breast tissue, 322 cases/616 cores
LC6161, High-density lung cancer array, with stage, grade and normal lung tissue, 322 cases/616 cores
KD2084, Renal disease spectrum tissue array, with stage and TNM info, 104 cases/208 cores
ST961, Stomach adenocarcinoma tissue array, including TNM and pathology grade, 48 cases/96 cores
OR2081, Oral cavity disease spectrum (oral cancer progression) tissue array, 98 cases/208 cores
FDA999b, Multiple organ normal tissue array, 47 cases/99 cores, replaced by FDA999c
BR10010a, Breast cancer and matched metastatic carcinoma tissue array, including TNM and pathology grade, with ER, PR and Her-2 (neu) IHC results, 50 cases/100 cores, replacing BR10010
BR805, Breast infiltrating lobular carcinoma tissue array, 80 cases/80 cores
GL803, Brain tumor tissue array of glioblastoma, astrocytoma, ependymoma, oligo astrocytoma, medulloblastoma and oligodendroglioma, 78 cases/80 cores, replaced by GL803a
BN04011, Normal lung tissue (multi-sites) tissue array, 22 cases/63 cores, replaced by LC725
TP242, Top 4 types of cancer (colon, breast, prostate and lung) 24 core test tissue array, 24 cases/24 cores, replaced by TP242a
BCC38218, Metastatic malignant melanoma tissue array, 50 cases/100 cores
BR1003, Breast pre-cancerous disease and cancer tissue array (100 cases/101 cores), with clinical stage and pathology grade data
MC803, Retinoblastoma, nephroblastoma, neuroblastoma and leukemia tissue array, 40 cases/80 cores, replaced by MC803a
ME1004a, Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM and clinical stage, 100 cases/100 cores, replaced by ME1004b
BR1503a, Breast cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores, with IHC results of Her-2, ER, PR, AR, P53 and Ki67, 75 cases/150 cores, replaced by BR1503b
BM482, Multiple myeloma tissue microarray with normal tissue as control, 24 cases/48 cores, replaced by BM483a
LY6161, High-density lymphoma and normal lymph node tissue array, 322 cases/616 cores
ME1003, Malignant melanoma, metastatic malignant melanoma and benign nevus tissue array, including TNM and clinical stage, 100 cases/100 cores, replaced by ME1004

Newly added tissue microarrays in recent month:

2015-01-19 CO803a, Colon cancer tissue array with matched cancer adjacent colon tissue as contral, including TNM, clinical stage and pathology grade, 40 cases/80 cores, replcing CO803
2015-01-19 BC12011b, Bladder cancer tissue array, including TNM, clinical stage and pathology grade, 63 cases/63 cores, replacing BC12011a
2015-01-19 PR807b, Prostate cancer, hyperplasia and prostate tissue array as control, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replacing PR807a
2015-01-17 H100C17, Repeat-Sequence-Free HER-2/CEN17 FISH Probe 1) It covers a 100kb chromosome region at 17q12, including the 40kb entire HER-2 gene region in the middle. 2) Chromosome 17 specific alpha satellite DNA
2015-01-17 H40C17, Repeat-Sequence-Free HER-2 Only FISH Probe 1) It targets exactly the 40kb HER-2 gene region on chromosome 17. 2) Chromosome 17 specific alpha satellite DNA
2015-01-17 H250C17, HER-2/CEN17 FISH Probe 1) It covers a ~248kb chromosome region at 17q11.2-q12, which includes the entire HER-2 gene. 2) Chromosome 17 specific alpha satellite DNA
2015-01-16 CR602a, Uterine cervix disease spectrum tissue array, including TNM, clinical stage and pathology grade, 60 cases/ 60 cores, replacing CR602
2015-01-13 FLU401, Frozen lung cancer tissue array with adjacent normal lung tissue as control, 40 cases/40 cores
2015-01-12 OV701, Ovary cancer tissue array and adjacent normal ovary tissue, including TNM, clinical stage and pathology grade, 70 cases/70 cores, replacing BC111110
2015-01-09 FDA999g, Multiple organ normal tissue array, 97 cases/99 cores, replacing FDA999f
2015-01-05 PR1921, Prostate cancer tissue array, adjacent normal prostate tissue and normal tissue as control, including TNM, clinical stage and pathology grade and IHC markers (PSA) results, 96 cases/192 cores
2014-12-30 T195c, Prostate cancer test tissue array, including TNM, clinical stage and pathology grade and IHC markers (PSA) results, 12 cases/24 cores, replacing T195b
2014-12-30 PA1001a, Pancreatic cancer tissue array, with adjacent normal pancreas tissue and normal tissue as control, including TNM, clinical stage and pathology grade, 50 cases/100 cores, replacing PA1001
2014-12-29 LC241b, Lung cancer tissue array with matched adjacent normal lung tissue, including TNM, clinical stage and pathology grade, 6 cases/24 cores, replacing LC241a
2014-12-29 BR243u, Breast cancer tissue array with matched adjacent normal breast tissue as control, including TNM, clinical stage and pathology grade and IHC markers (ER, PR, Her-2) results, 6 cases/24 cores, replacing BR243s
2014-12-22 BL631, Bladder cancer tissue array with matched adjacent normal bladder tissue, including TNM and pathology grade, 24 cases/63 cores
2014-12-22 ME1004c, Malignant melanoma, metastatic malignant melanoma and nevus tissue array, including TNM, clinical stage and pathology grade, with IHC results of HMB45, 100 cases/100 cores, replacing ME1004b
2014-12-15 BN243c, Multiple organ normal tissue array, 12 cases/24 cores, replacing BN243b
2014-12-15 PA483c, Pancreas cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 48 cases/48 cores, replacing PA483b
2014-12-08 KD321, Kidney cancer tissue array with matched adjacent normal tissue, including TNM, clinical stage and pathology grade, 16 cases/32 cores